ZUO LI YAO YE(SZ:300181)2026-03-24 09:14Group 1: Product Strategy and Market Expansion - The company launched a new brand for its product "Wuling" in early 2026, emphasizing a dual-channel strategy to enhance its influence in the C-end market [1] - Key initiatives include the introduction of a large packaging of 108 capsules, strengthening partnerships with major chain pharmacies, and expanding into e-commerce and O2O retail channels [1] - The company organized the first "Wuling Sleep King Challenge" during World Sleep Day 2026, promoting scientific sleep concepts through immersive experiences [2] Group 2: Financial Instruments and R&D Investment - The company has initiated the issuance of convertible bonds, which is currently under the first round of inquiry by the Shenzhen Stock Exchange [3] - R&D investments focus on innovative traditional Chinese medicine, particularly the Wuling series, aiming to develop a family of 10 products [4] - Additional R&D efforts include secondary development of Wuling capsules and expanding clinical applications [4] Group 3: Market Coverage and Sales Performance - Wuling capsules are currently available in six provinces, including Shanghai and Zhejiang, where prices are higher than in regions under centralized procurement, accounting for approximately one-third of total sales [5] - The product has reached about 16,000 medical institutions nationwide, with significant room for growth as there are over 1 million medical institutions in total [6]